News Releases
February 27, 2013
CLEVELAND - A ºÚÁϳԹÏÍø professor has found that young people addicted to alcohol and drugs can increase their chances of recovery by helping others.
In 2010, Maria Pagano, PhD, found that adults who became involved in Alcoholics Anonymous-related service-type work were more l...
February 14, 2013
CLEVELAND - A research team from ºÚÁϳԹÏÍø School of Medicine has discovered an approach that could make gene therapy dramatically more effective for patients.
Led by professor Eric Arts, PhD, the scientists discovered that the process of gene therapy is missing essential elem...
February 08, 2013
CLEVELAND - ºÚÁϳԹÏÍø School of Medicine has received a $220,000 grant from the DeGregorio Family Foundation to study gastric cancers, which remain among the most deadly forms of disease.
The two-year grant from the foundation, which focuses on stomach and esophageal cancer re...
January 23, 2013
CLEVELAND - A team of researchers led by Goutham Narla, MD, PhD, at ºÚÁϳԹÏÍø School of Medicine and University Hospitals Case Medical Center, and collaborators at the Mount Sinai School of Medicine and Erasmus Medical Center, have discovered a gene variant that drives the spre...
January 09, 2013
CLEVELAND - The discovery of insulin nearly a century ago changed diabetes from a death sentence to a chronic disease.
Today a team that includes researchers from ºÚÁϳԹÏÍø School of Medicine announced a discovery that could lead to dramatic improvements in the lives of people...
December 27, 2012
CLEVELAND - ºÚÁϳԹÏÍø has been approved for a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study ways that applying patients’ strengths can help enhance their health care and well-being. The project is part of a portfolio of patient-centered c...
December 17, 2012
CLEVELAND - Researchers at ºÚÁϳԹÏÍø School of Medicine have identified a molecule linked to more aggressive forms of breast cancer – a discovery that could point the way to potential cures.
Until this study, the ribonucleic acid (RNA) molecule called miR-181a had never before...
December 11, 2012
CLEVELAND - ºÚÁϳԹÏÍø School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV ...
December 05, 2012
CLEVELAND - ºÚÁϳԹÏÍø School of Medicine announced that it will receive funding through the Achieving Healthy Growth program within the Grand Challenges in Global Health initiative. This initiative was launched by the Bill & Melinda Gates Foundation to overcome persistent bottl...
November 19, 2012
CLEVELAND - Researchers at ºÚÁϳԹÏÍø School of Medicine have identified a genetic factor that prevents blockages from forming in blood vessels, a discovery that could lead to new therapies for cardiovascular diseases.
The findings are described in the Nov. 19 issue of the Jour...